1. Home
  2. MREO vs FPI Comparison

MREO vs FPI Comparison

Compare MREO & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • FPI
  • Stock Information
  • Founded
  • MREO 2015
  • FPI 2013
  • Country
  • MREO United Kingdom
  • FPI United States
  • Employees
  • MREO N/A
  • FPI N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • FPI Real Estate Investment Trusts
  • Sector
  • MREO Health Care
  • FPI Real Estate
  • Exchange
  • MREO Nasdaq
  • FPI Nasdaq
  • Market Cap
  • MREO 438.8M
  • FPI 516.0M
  • IPO Year
  • MREO N/A
  • FPI 2014
  • Fundamental
  • Price
  • MREO $1.76
  • FPI $10.59
  • Analyst Decision
  • MREO Strong Buy
  • FPI
  • Analyst Count
  • MREO 5
  • FPI 0
  • Target Price
  • MREO $7.20
  • FPI N/A
  • AVG Volume (30 Days)
  • MREO 4.4M
  • FPI 450.9K
  • Earning Date
  • MREO 08-12-2025
  • FPI 07-23-2025
  • Dividend Yield
  • MREO N/A
  • FPI 2.27%
  • EPS Growth
  • MREO N/A
  • FPI 229.01
  • EPS
  • MREO N/A
  • FPI 1.21
  • Revenue
  • MREO N/A
  • FPI $55,000,000.00
  • Revenue This Year
  • MREO N/A
  • FPI N/A
  • Revenue Next Year
  • MREO $51.92
  • FPI N/A
  • P/E Ratio
  • MREO N/A
  • FPI $8.78
  • Revenue Growth
  • MREO N/A
  • FPI N/A
  • 52 Week Low
  • MREO $1.57
  • FPI $9.66
  • 52 Week High
  • MREO $5.02
  • FPI $12.87
  • Technical
  • Relative Strength Index (RSI)
  • MREO 35.35
  • FPI 31.87
  • Support Level
  • MREO $1.65
  • FPI $11.00
  • Resistance Level
  • MREO $1.89
  • FPI $11.58
  • Average True Range (ATR)
  • MREO 0.15
  • FPI 0.25
  • MACD
  • MREO -0.03
  • FPI -0.06
  • Stochastic Oscillator
  • MREO 12.84
  • FPI 10.04

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: